Return to content in this issue

 

Maraviroc, a future treatment of sarcoidosis? An unexpected drug effect

Goehringer F1, Tiotiu A2, Schvoerer E3, Jaussaud R4, Hoen B1

1Infectious Diseases Department, Nancy University Hospital, Nancy, France
2Pulmonology Department, Nancy University Hospital, Nancy, France
3Laboratory of Virology, Nancy University Hospital, Nancy, France
4Internal Medicine and Clinical Immunology Department, Nancy University Hospital, Nancy, France

J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0537

Key words: Maraviroc, HIV-infection, Sarcoidosis, CD4+ lymphocytopenia, Th1-inflammation

Title Type Size
doi10.1876_jiaci.0537_material-suppl.pdf pdf 551.48 Kb